Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 105

Similar articles for PubMed (Select 21908983)

1.

The role of NT-proBNP in explaining the variance in anaerobic threshold and VE/VCO(2) slope.

Athanasopoulos LV, Dritsas A, Doll HA, Cokkinos DV.

J Cardiopulm Rehabil Prev. 2011 Sep-Oct;31(5):316-21. doi: 10.1097/HCR.0b013e31822c0afb.

PMID:
21908983
2.

Explanation of the variance in quality of life and activity capacity of patients with heart failure by laboratory data.

Athanasopoulos LV, Dritsas A, Doll HA, Cokkinos DV.

Eur J Cardiovasc Prev Rehabil. 2010 Aug;17(4):375-9. doi: 10.1097/HJR.0b013e328333e962.

PMID:
19940776
3.

Exercise oscillatory breathing and increased ventilation to carbon dioxide production slope in heart failure: an unfavorable combination with high prognostic value.

Guazzi M, Arena R, Ascione A, Piepoli M, Guazzi MD; Gruppo di Studio Fisiologia dell'Esercizio, Cardiologia dello Sport e Riabilitazione Cardiovascolare of the Italian Society of Cardiology.

Am Heart J. 2007 May;153(5):859-67.

PMID:
17452165
4.

[Diagnostic value of the currently used criteria and brain natriuretic peptide for diagnosing congestive heart failure in children with congenital heart disease].

Wu YR, Chen SB, Sun K, Huang MR, Zhang YQ, Chen S.

Zhonghua Er Ke Za Zhi. 2006 Oct;44(10):728-32. Chinese.

PMID:
17229370
5.

Exercise oscillatory breathing and NT-proBNP levels in stable heart failure provide the strongest prediction of cardiac outcome when combining biomarkers with cardiopulmonary exercise testing.

Guazzi M, Boracchi P, Labate V, Arena R, Reina G.

J Card Fail. 2012 Apr;18(4):313-20. doi: 10.1016/j.cardfail.2012.01.006. Epub 2012 Feb 17.

PMID:
22464773
7.

VE/VCO2 slope and oxygen uptake efficiency slope in patients with coronary artery disease and intermediate peakVO2.

Van de Veire NR, Van Laethem C, Philippé J, De Winter O, De Backer G, Vanderheyden M, De Sutter J.

Eur J Cardiovasc Prev Rehabil. 2006 Dec;13(6):916-23.

PMID:
17143123
8.

Peak VO2 and VE/VCO2 slope in patients with heart failure: a prognostic comparison.

Arena R, Myers J, Aslam SS, Varughese EB, Peberdy MA.

Am Heart J. 2004 Feb;147(2):354-60.

PMID:
14760336
9.
10.

Role of the plasma brain natriuretic peptide in differentiating patients with congestive heart failure from other diseases.

Sirithunyanont C, Leowattana W, Sukumalchantra Y, Chaisupamonkollarp S, Watanawaroon S, Chivatanaporn B, Bhuripanyo K, Mahanonda N.

J Med Assoc Thai. 2003 May;86 Suppl 1:S87-95.

PMID:
12866774
11.

Diagnostic and prognostic performance of N-terminal ProBNP in primary care patients with suspected heart failure.

Gustafsson F, Steensgaard-Hansen F, Badskjaer J, Poulsen AH, Corell P, Hildebrandt P.

J Card Fail. 2005 Jun;11(5 Suppl):S15-20.

PMID:
15948095
12.

Comparison of the effects of carvedilol and metoprolol on exercise ventilatory efficiency in patients with congestive heart failure.

Kataoka M, Satoh T, Yoshikawa T, Nakamura I, Kohno T, Yoshizawa A, Anzai T, Ogawa S.

Circ J. 2008 Mar;72(3):358-63.

13.

Direct comparison of B-type natriuretic peptide (BNP) and amino-terminal proBNP in a large population of patients with chronic and symptomatic heart failure: the Valsartan Heart Failure (Val-HeFT) data.

Masson S, Latini R, Anand IS, Vago T, Angelici L, Barlera S, Missov ED, Clerico A, Tognoni G, Cohn JN; Val-HeFT Investigators.

Clin Chem. 2006 Aug;52(8):1528-38. Epub 2006 Jun 15.

14.

Atrial fibrillation and amino-terminal pro-brain natriuretic peptide as independent predictors of prognosis in systolic heart failure.

Dini FL, Gabutti A, Passino C, Fontanive P, Emdin M, De Tommasi SM.

Int J Cardiol. 2010 Apr 30;140(3):344-50. doi: 10.1016/j.ijcard.2008.11.108. Epub 2009 Jan 6.

PMID:
19128846
15.

Technical considerations related to the minute ventilation/carbon dioxide output slope in patients with heart failure.

Arena R, Myers J, Aslam SS, Varughese EB, Peberdy MA.

Chest. 2003 Aug;124(2):720-7.

PMID:
12907564
16.

Amino-terminal pro-brain natriuretic peptid in prediction of left ventricular ejection fraction.

Bajrić M, Baraković F, Kusljugić Z, Salkić N, Jahić E, Ascerić M, Ljuca F, Mrsić D, Smajić E, Caluk J, Hajrić R.

Bosn J Basic Med Sci. 2008 Aug;8(3):282-6.

PMID:
18816264
17.

Incremental value of N-terminal pro-brain natriuretic peptide over left ventricle ejection fraction and aerobic capacity for estimating prognosis in heart failure patients.

Kallistratos MS, Dritsas A, Laoutaris ID, Cokkinos DV.

J Heart Lung Transplant. 2008 Nov;27(11):1251-6. doi: 10.1016/j.healun.2008.07.030.

PMID:
18971099
18.

[The diagnostic value of N-terminal B-type natriuretic peptide in diastolic heart failure: comparison with echocardiographic findings].

Tuğcu A, Yildirimtürk O, Aytekin S.

Turk Kardiyol Dern Ars. 2009 Mar;37(2):112-21. Turkish.

PMID:
19404033
19.

Intravenous iron reduces NT-pro-brain natriuretic peptide in anemic patients with chronic heart failure and renal insufficiency.

Toblli JE, Lombraña A, Duarte P, Di Gennaro F.

J Am Coll Cardiol. 2007 Oct 23;50(17):1657-65.

20.

Renal function, congestive heart failure, and amino-terminal pro-brain natriuretic peptide measurement: results from the ProBNP Investigation of Dyspnea in the Emergency Department (PRIDE) Study.

Anwaruddin S, Lloyd-Jones DM, Baggish A, Chen A, Krauser D, Tung R, Chae C, Januzzi JL Jr.

J Am Coll Cardiol. 2006 Jan 3;47(1):91-7. Epub 2005 Dec 9.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk